Thus, our findings revealed that IL10- MSCs provided an effective method to resist the inflammatory responses and metabolic disorder caused by HFD feeding, indicating that inhibition of obesity-related inflammation based on cell therapy was an effective strategy in preventing obesity and obesity-related metabolic syndrome. This evidence concerns the gene IL10 and metabolic syndrome.